v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue   $ 2,550   $ 2,550
Costs and Operating Expenses        
Cost of revenue, excluding depreciation   670   670
Research and development expenses, excluding depreciation $ 59,387 18,923 $ 158,033 52,858
Selling, general and administrative expenses, excluding depreciation 45,510 8,405 144,072 15,897
Depreciation 2,109 1,738 6,317 5,179
Total costs and operating expenses 107,006 29,736 308,422 74,604
Loss from operations (107,006) (27,186) (308,422) (72,054)
Other (expense) income        
Interest income (expense) 33 (1,094) 79 (10,465)
(Loss) gain on fair value change in contingent earnout shares liability 25,764   101,166  
Loss on fair value change in private placement warrants liability     (1,639)  
Gain on extinguishment of debt   5,045   5,045
Other expense (income), net 334 (155) 160 (47)
Loss before income taxes (80,875) (23,390) (208,656) (77,521)
Net loss and comprehensive loss $ (80,875) $ (23,390) $ (208,656) $ (77,521)
Per Share Data:        
Net loss per share, basic and diluted $ (0.35) $ (0.20) $ (0.92) $ (0.82)
Weighted-average shares outstanding, basic and diluted 228,477,000 116,292,697 226,747,000 94,057,501

Source